References
Broen JC, Radstake TR, Rossato M. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 2014; 10: 671–81.
Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007; 3: 521–7.
Schoonen WM, Thomas SL, Somers EC, et al. Do selected drugs increase the risk of lupus? A matched case-control study. Br J Clin Pharmacol 2010; 70: 588–96.
Barragán-Martínez C, Speck-Hernández CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villarraga A. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PLoS One 2012; 7: e51506.
McCormic ZD, Khuder SS, Aryal BK, Ames AL, Khuder SA. Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int Arch Occup Environ Health 2010; 83: 763–9.
Teoh PC, Chan HL. Lupus-scleroderma syndrome induced by ethosuximide. Arch Dis Child 1975; 50: 658–61.
Itoh M, Yanaba K, Kobayashi T, Nakagawa H. Taxane-induced scleroderma. Br J Dermatol 2007; 156: 363–7.
Rubin RL. Drug-induced lupus. Toxicology 2005; 209: 135–47.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Toyama, T., Asano, Y., Taniguchi, T. et al. Ethosuximide-induced lupus-scleroderma syndrome with disease-specific autoantibodies. Eur J Dermatol 27, 196–197 (2017). https://doi.org/10.1684/ejd.2016.2942
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2016.2942